Close Menu

National Academy of Sciences

In an initial vote, the US National Academy of Sciences approved an amendment to allow the expulsion of members who violate its code of conduct, according to the Verge.

A commentary appearing in Nature calls for the establishment of a research policy board in the US.

Standards Needed

In an editorial, officials from scientific societies in the US and China call for the international community to develop criteria and standards for human germline editing.

Vox wonders whether gene-editing crops will be viewed similarly as genetically modified organisms of if people will give them a try.

Letting Them Know

A new report urges investigators to routinely consider returning research results to study participants, according to Stat News.

A new report highlights the potential threats posed by advances in synthetic biology, NPR reports.

The National Academies of Sciences, Engineering, and Medicine issues a new report on sexual harassment in the sciences.

For a Student Focus

A National Academies of Sciences, Engineering, and Medicine report calls for changing metrics to make STEM graduate school more student-centered, according to Science.

A Path to the Door

The US National Academies of Sciences, Engineering, and Medicine are to consider policy changes to be able to remove members who have committed sexual harassment, Science reports.

Inder Verma had been on leave from PNAS since December after three female scientists at the Salk Institute filed a lawsuit claiming gender discrimination.

Pages

A UK study on mixing SARS-CoV-2 vaccines is expanding to include vaccines developed by additional companies, according to the Guardian.

According to Science, the US National Academy of Sciences is poised to eject two members accused of sexual harassment.

In Nucleic Acids Research this week: machine learning approach to detect DNA-bound proteins, CRISPR-based method for activating specific gene targets, and more.

The FDA and CDC call for a pause in administering Johnson & Johnson's SARS-CoV-2 vaccine while reports of rare blood clots are looked into, reports the Wall Street Journal.